ID
14926
Descripción
This study will evaluate the safety, reactogenicity and immunogenicity of a booster dose of GSK Biologicals' pneumococcal conjugate vaccine compared to Prevenar™ given at 12-18 mo of age to children primed with either pneumococcal vaccine or Prevenar™ in study 105553. Antibody persistence will be evaluated at 8-14 mo after completion of the 3-dose immunization course in study 105553. The immune response to a booster dose of GSK Biologicals' pneumococcal conjugate vaccine will also be evaluated when given at 12-18 mo to subjects not primed with GSK Biologicals' vaccine but with Prevenar™. The study has 3 groups. 1 group of children primed with GSK Biologicals' pneumococcal conjugate vaccine will receive a booster dose of the same vaccine. 2nd group of children primed with Prevenar™ will receive a booster dose of Prevenar™ (control group). 3rd group of children primed with Prevenar™ will receive a booster dose of GSK Biologicals' pneumococcal conjugate vaccine. All children will receive concomitantly a booster dose of DTPa-HBV-IPV/Hib vaccine. NCT00370396 Part: Adverse Events
Palabras clave
Versiones (1)
- 8/5/16 8/5/16 -
Subido en
8 de mayo de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Adverse Events Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals 10-valent Pneumococcal Conjugate Vaccine NCT00370396
Adverse Events "Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine" NCT00370396
Descripción
Local Symptoms
Alias
- UMLS CUI-1
- C1457887
- UMLS CUI-2
- C0205276
Descripción
Type of Vaccine Administered
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0087111
Descripción
If yes, please tick No/Yes for each symptom. If Yes is ticked, please complete all items. If any of these adverse events meets the protocol definition of serious, please complete a Serious Adverse Event report and fax to GSK Biologicals Study Contact for SAE reporting within 24 hours.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1457887
- UMLS CUI [1,2]
- C0205276
Descripción
In case of large swelling reaction at the injected limb, please fill in ALSO the Large Swelling Reaction forms.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1457887
Descripción
Intensity: 0,1,2,3 (see Adverse Events definitions)
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0005890
- UMLS CUI [2]
- C0518690
Descripción
Intensity: 0,1,2,3 (see Adverse Events definitions)
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0005890
- UMLS CUI [2]
- C0518690
Descripción
Intensity: 0,1,2,3 (see Adverse Events definitions)
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0005890
- UMLS CUI [2]
- C0518690
Descripción
Intensity: 0,1,2,3 (see Adverse Events definitions)
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0005890
- UMLS CUI [2]
- C0518690
Descripción
If yes name date of last Symptoms below
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0449238
Descripción
Date of last day of symptoms
Tipo de datos
date
Alias
- UMLS CUI [1]
- C2004454
Descripción
if yes, please specify the place below
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0545082
Descripción
Place of Medical Attendance
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0018704
Descripción
General Symptoms
Descripción
General Symptoms specification
Descripción
If Fever, please specify below.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1457887
- UMLS CUI [1,2]
- C0205246
Descripción
Fever Measuring Route
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013153
Descripción
Fever: Axillary >37.5°C Oral >37.5°C Rectal >38.0°C Tympanic (oral conversion) >37.5°C Tympanic (rectal conversion) >38.0°C Intensity: 0,1,2,3
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0518690
- UMLS CUI [2]
- C0039476
Descripción
Intensity/°C Day 1
Tipo de datos
text
Descripción
Intensity/°C Day 2
Tipo de datos
text
Descripción
Intensity/°C Day 3
Tipo de datos
text
Descripción
Ongiong after Day 3
Tipo de datos
text
Descripción
Date of last day of symptoms
Tipo de datos
date
Alias
- UMLS CUI [1]
- C2004454
Descripción
Casualty
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0011065
Descripción
Medically Attended visit
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0545082
Descripción
Health Care Facility
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0018704
Descripción
Unsolicited Adverse Events
Descripción
If Yes: Fill in the Non-Serious Adverse Event section or Serious Adverse Event report as necessary.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0877248
Descripción
Meningitis
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0025289
Similar models
Adverse Events "Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine" NCT00370396
C0805701 (UMLS CUI [1,2])
C0518690 (UMLS CUI [2])
C0518690 (UMLS CUI [2])
C0518690 (UMLS CUI [2])
C0518690 (UMLS CUI [2])
C0205246 (UMLS CUI [1,2])
C0039476 (UMLS CUI [2])